NAMS
NAMS
NASDAQ · Biotechnology

Newamsterdam Pharma Co Nv

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$23.32
+0.74 (+3.28%)
As of Sep 22, 9:56 PM ET ·
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 21 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target +56.0% upside
Low Target $23.00
Average Target $36.39
High Target $47.36
Current Price $23.32
Current
$23.32
Target
$36.39
$23.00 $36.39 avg $47.36
Scenario Analysis
Bear Case
$23.00
-1.4%
Low target
Base Case
$36.39
+56.0%
Avg target
Bull Case
$47.36
+103.1%
High target
Risk/Reward
75.1x
Highly favorable
Price in Context
52-Week High
$42.21
-44.7% from high
52-Week Low
$21.02
+10.9% from low
50-Day SMA
$34.11
-31.6% vs SMA
200-Day SMA
$28.53
-18.3% vs SMA
RSI (14)
66.1
Neutral
Target vs 52W High
$36.39
-13.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%